🔎 Trials Near Me

Akèy › Skizofreni › Georgia › Atlanta

Etid klinik pou Skizofreni nan Atlanta, GA

22 etid pou Skizofreni ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Ap rekriteFaz 4
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Decatur · 6 mi lwen
Laj 12 a 17 · Tout sèks · Mizajou Oct 1, 2026 · NCT05648591

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Ap rekriteFaz 1
  • Synexus Clinical Research US Inc, Atlanta
Laj 18 a 55 · Tout sèks · Mizajou Sep 28, 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Ap rekriteFaz 3
  • Atlanta Center for Medical Research, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Sep 28, 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

Ap rekriteFaz 3
  • CenExeli Research LLC, Atlanta
  • Atlanta Center for Medical Research, Atlanta
Laj 5 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Ap rekriteFaz 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi lwen
Laj 5 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

Ap rekriteFaz 2
  • Atlanta Center for Medical Research, Atlanta
Laj 18 a 55 · Tout sèks · Mizajou Sep 22, 2026 · NCT07410507

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

Ap rekriteFaz 1
  • CenExel iResearch, LLC, Decatur · 6 mi lwen
Laj 18 a 55 · Tout sèks · Mizajou Sep 17, 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

Ap rekriteFaz 3
  • CenExel, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Sep 9, 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Ap rekriteFaz 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi lwen
Laj 13 a 17 · Tout sèks · Mizajou Sep 4, 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

Ap rekriteFaz 1
  • Atlanta Center for Medical Research, Atlanta
  • CenExel iResearch, LLC, Decatur · 6 mi lwen
Laj 18 a 55 · Tout sèks · Mizajou Sep 2, 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Ap rekriteFaz 2
  • Clinical Site, Atlanta
  • Clinical Site, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 1, 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Ap rekriteEtid obsèvasyon
  • Emory University., Atlanta
  • Local Institution - 0049, Austell · 15 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Ap rekriteFaz 3
  • Alkermes Investigator Site, Decatur · 6 mi lwen
Laj 10 a 17 · Tout sèks · Mizajou Aug 14, 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Ap rekriteFaz 1
  • Bioxcel Clinical Research Site, Decatur · 6 mi lwen
Laj 10 a 17 · Tout sèks · Mizajou Aug 11, 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

Ap rekriteFaz 2
  • CenExel iResearch, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07467993

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

Ap rekriteFaz 2
  • Cenexel ACMR, Atlanta
  • Cenexel iResearch Atlanta, Decatur · 6 mi lwen
Laj 18 a 55 · Tout sèks · Mizajou Jun 23, 2026 · NCT07191483

Anti-Inflammatory Challenge in Schizophrenia

Ap rekriteFaz 4
  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
Laj 18 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05823532

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Ap rekriteFaz 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Mar 6, 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

Ap rekriteFaz 3
  • Vanda Investigational Site, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou Jan 12, 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Ap rekriteFaz 3Volontè an sante akeyi
  • Reviva site, Atlanta
  • Reviva site, Decatur · 6 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Dec 19, 2024 · NCT05184335

Etid Skizofreni nan lòt vil

Lòt etid nan Atlanta

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.